Position in ANNX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$884,571
+$249,727 QoQ
Shares Held
159,670
+26.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 21.432955470658232.ToString("F0")%
Shared 0.ToString("F0")%
None 78.56704452934177.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. ANNX ranks #124 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ANNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $884,571 | 159,670 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $634,844 | 126,463 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $404,439 | 132,603 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $330,086 | 137,536 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $263,252 | 136,400 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $727,700 | 141,852 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $805,108 | 135,998 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $620,629 | 126,659 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $587,782 | 81,978 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $269,312 | 59,320 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $140,915 | 59,710 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $193,705 | 55,030 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $106,243 | 38,917 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $434,034 | 37,775 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $712,409 | 38,281 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $828,503 | 36,806 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $707,024 | 25,396 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $394,798 | 15,773 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $396,496 | 13,116 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||